Order Article Reprints

Amorim VMdF, Soares EP, Ferrari ASdA, Merighi DGS, de Souza RF, Guzzo CR, Souza ASd. 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials. Viruses. 2024; 16(6):844. https://doi.org/10.3390/v16060844

Amorim, Vitor Martins de Freitas, Eduardo Pereira Soares, Anielle Salviano de Almeida Ferrari, Davi Gabriel Salustiano Merighi, Robson Francisco de Souza, Cristiane Rodrigues Guzzo, and Anacleto Silva de Souza. 2024. "3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials" Viruses 16, no. 6: 844. https://doi.org/10.3390/v16060844

Amorim, V. M. d. F., Soares, E. P., Ferrari, A. S. d. A., Merighi, D. G. S., de Souza, R. F., Guzzo, C. R., & Souza, A. S. d. (2024). 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials. Viruses, 16(6), 844. https://doi.org/10.3390/v16060844